UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Results of a follow-up study to the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT)

Alzheimer's & dementia, 2013-11, Vol.9 (6), p.714-723

Anon., Anon

2013

Volltextzugriff (PDF)

Follow-up evaluation of cognitive function in the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial and its Follow-up Study

Alzheimer's & dementia, 2015-02, Vol.11 (2), p.216-225.e1

2015

Volltextzugriff (PDF)

Circadian disturbances, risk for postoperative delirium and conversion to dementia

Alzheimer's & dementia, 2023-06, Vol.19 (S2), p.n/a

2023

Volltextzugriff (PDF)

Formal Care Providers Experiences with Indigenous Understandings of the Stages of Dementia in Diverse Indigenous Communities in Canada and the United States

Alzheimer's & dementia, 2023-12, Vol.19 (S19), p.n/a

2023

Volltextzugriff (PDF)

Memory Keepers Medical Discovery Team: addressing Indigenous dementia disparities through deep exploration of culture and community‐specific context

Alzheimer's & dementia, 2023-12, Vol.19 (S20), p.n/a

2023

Volltextzugriff (PDF)

Relational, Community Dementia Care for All: Observations and Lessons from On‐Reservation Providers, Administrators, and Formal Caregivers in the US and Canada

Alzheimer's & dementia, 2023-12, Vol.19 (S19), p.n/a

2023

Volltextzugriff (PDF)

Characterisation of Alzheimer’s disease patients with agitation and their antipsychotic use: A study using the UK Clinical Practice Research Datalink

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Volltextzugriff (PDF)

Characterisation of Alzheimer’s disease patients with agitation and their antipsychotic use: A study using the UK Clinical Practice Research Datalink: Managing dementia‐related behaviors

Alzheimer's & dementia, 2020-12, Vol.16 (S8)

2020

Volltextzugriff (PDF)

AHEAD 3‐45 study: Preliminary screening and baseline characteristics from a placebo‐controlled, double‐blind study evaluating lecanemab in participants with preclinical Alzheimer’s disease and elevated (A45 trial) and intermediate (A3 trial) amyloid

Alzheimer's & dementia, 2021-12, Vol.17 (S9), p.n/a

2021

Volltextzugriff (PDF)

Indigenous cultural understandings of Alzheimer’s disease and related dementias – research and engagement (ICARE): relationships between cultural strengths, education and stigma

Alzheimer's & dementia, 2022-12, Vol.18 (S8), p.n/a

2022

Volltextzugriff (PDF)

What does it take to get a diagnosis? Dementia recognition and diagnosis pathways among Indigenous peoples

Alzheimer's & dementia, 2022-12, Vol.18 (S8), p.n/a

2022

Volltextzugriff (PDF)

AB42 and polyamines: Elucidating a potential mechanism of amyloid‐mediated apoptosis and aggregation: Molecular and cell biology/APP/Abeta/amyloid

Alzheimer's & dementia, 2020-12, Vol.16 (S2)

2020

Volltextzugriff (PDF)

AB42 and polyamines: Elucidating a potential mechanism of amyloid‐mediated apoptosis and aggregation

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Volltextzugriff (PDF)

AHEAD 3‐45 study design: A global study to evaluate the efficacy and safety of treatment with BAN2401 for 216 weeks in preclinical Alzheimer’s disease with intermediate amyloid (A3 trial) and elevated amyloid (A45 trial)

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Volltextzugriff (PDF)

AHEAD 3‐45 study design: A global study to evaluate the efficacy and safety of treatment with BAN2401 for 216 weeks in preclinical Alzheimer’s disease with intermediate amyloid (A3 trial) and elevated amyloid (A45 trial): Clinical trial design and implementation

Alzheimer's & dementia, 2020-12, Vol.16 (S9)

2020

Volltextzugriff (PDF)

Cross‐sectional comparison of the role of tau burden among Down Syndrome Alzheimer disease and autosomal‐dominant Alzheimer disease

Alzheimer's & dementia, 2023-12, Vol.19 (S14), p.n/a

2023

Volltextzugriff (PDF)

APOE4‐stratified GWAS across cognitive domains in non‐Hispanic white and non‐Hispanic black individuals

Alzheimer's & dementia, 2023-12, Vol.19 (S12), p.n/a

2023

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Zeitschrift / SerieAlzheimer's & Dementia

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(59)

Sprache

Englisch
(59)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Neurology
(16)
Humans
(5)
Clinical Neurology
(4)
Life Sciences & Biomedicine
(4)
Neurosciences & Neurology
(4)
Science & Technology
(4)
Aged
(3)
Alzheimer's Disease
(3)
Female
(3)
Male
(3)
Aged, 80 And Over
(2)
Anti-Inflammatory Agents - Therapeutic Use
(2)
Biomarkers
(2)
Celecoxib
(2)
Clinical Trial
(2)
Longitudinal Studies
(2)
Naproxen
(2)
Naproxen - Therapeutic Use
(2)
Nonsteroidal Anti-Inflammatory Drug
(2)
Nonsteroidal Anti‐inflammatory Drug
(2)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Wiley Online Library Journals Frontfile Complete
(59)
Journals@Ovid Complete
(59)
Ingenta.com
(59)
Elsevier ScienceDirect Journals Complete
(59)
IngentaConnect Journals
(16)
MEDLINE
(5)
Applied Social Sciences Index & Abstracts (ASSIA)
(1)
EZB Electronic Journals Library
(1)

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
(1)

Menü

Weitere Dienste

Einstellungen

Results of a follow-up study to the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT)

Follow-up evaluation of cognitive function in the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial and its Follow-up Study

Circadian disturbances, risk for postoperative delirium and conversion to dementia

Current directions in tau research: Highlights from Tau 2020

Formal Care Providers Experiences with Indigenous Understandings of the Stages of Dementia in Diverse Indigenous Communities in Canada and the United States

Memory Keepers Medical Discovery Team: addressing Indigenous dementia disparities through deep exploration of culture and community‐specific context

Relational, Community Dementia Care for All: Observations and Lessons from On‐Reservation Providers, Administrators, and Formal Caregivers in the US and Canada

Characterisation of Alzheimer’s disease patients with agitation and their antipsychotic use: A study using the UK Clinical Practice Research Datalink

Characterisation of Alzheimer’s disease patients with agitation and their antipsychotic use: A study using the UK Clinical Practice Research Datalink: Managing dementia‐related behaviors

APPLE‐Tree remote secondary dementia prevention; opportunities for scalable public health interventions to reduce dementia risk

AHEAD 3‐45 study: Preliminary screening and baseline characteristics from a placebo‐controlled, double‐blind study evaluating lecanemab in participants with preclinical Alzheimer’s disease and elevated (A45 trial) and intermediate (A3 trial) amyloid

Functional variations in gamma‐secretase processing of APP are critical determinants of the clinical, biomarker, and cognitive progression of autosomal dominant Alzheimer’s disease

Plasma levels of an N‐terminal tau fragment predict core AD and neurodegenerative biomarkers in autosomal dominant Alzheimer’s disease: Findings from DIAN

Developing an Ethnographic Community‐Based Participatory Research Dementia Study with Diverse Indigenous Populations: Indigenous Cultural understandings of Alzheimer’s disease and related dementias – Research and Engagement (ICARE) project

Indigenous cultural understandings of Alzheimer’s disease and related dementias – research and engagement (ICARE): relationships between cultural strengths, education and stigma

What does it take to get a diagnosis? Dementia recognition and diagnosis pathways among Indigenous peoples

Genetic predictors of multiple cognitive domains within ancestry groups in older adults

Sex‐specific genetic architecture of multiple domains of cognition among older adults

Genetic architecture of multiple domains of cognition among SuperAgers

AB42 and polyamines: Elucidating a potential mechanism of amyloid‐mediated apoptosis and aggregation: Molecular and cell biology/APP/Abeta/amyloid

AB42 and polyamines: Elucidating a potential mechanism of amyloid‐mediated apoptosis and aggregation

AHEAD 3‐45 study design: A global study to evaluate the efficacy and safety of treatment with BAN2401 for 216 weeks in preclinical Alzheimer’s disease with intermediate amyloid (A3 trial) and elevated amyloid (A45 trial)

AHEAD 3‐45 study design: A global study to evaluate the efficacy and safety of treatment with BAN2401 for 216 weeks in preclinical Alzheimer’s disease with intermediate amyloid (A3 trial) and elevated amyloid (A45 trial): Clinical trial design and implementation

Cross‐sectional comparison of the role of tau burden among Down Syndrome Alzheimer disease and autosomal‐dominant Alzheimer disease

APOE4‐stratified GWAS across cognitive domains in non‐Hispanic white and non‐Hispanic black individuals

Aktive Filter

Suchergebnisse filtern